Cost-utility of colorectal cancer screening at 40 years old for average-risk patients.
Ontology highlight
ABSTRACT: The incidence of colorectal cancer (CRC) is increasing in patients under the age of 50. The purpose of this study was to assess the cost-utility of available screening modalities starting at 40 years in the general population compared to standard screening at 50 years old. A decision tree modeling average-risk of CRC in the United States population was constructed for the cost per quality-adjusted life year (QALY) of the five most common and effective CRC screening modalities in average-risk 40-year olds versus deferring screening until 50 years old (standard of care) under a limited societal perspective. All parameters were derived from existing literature. We evaluated the incremental cost-utility ratio of each comparator at a willingness-to-pay threshold of $50,000/QALY and included mul
SUBMITTER: Azad NS
PROVIDER: S-EPMC8710143 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA